Literature DB >> 7023986

The major proglucagon fragment: an abundant islet protein and secretory product.

C Patzelt, G Schug.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7023986     DOI: 10.1016/0014-5793(81)80772-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Discovery, characterization, and clinical development of the glucagon-like peptides.

Authors:  Daniel J Drucker; Joel F Habener; Jens Juul Holst
Journal:  J Clin Invest       Date:  2017-12-01       Impact factor: 14.808

3.  Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences.

Authors:  C Patzelt; E Schiltz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Differential inhibitory action of cationic amino acids on protein synthesis in pancreatic rat islets.

Authors:  C Patzelt
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

Review 5.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

6.  Early O-glycosidic glycosylation of proglucagon in pancreatic islets: an unusual type of prohormonal modification.

Authors:  C Patzelt; B Weber
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

Review 7.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.